An estimated 234,000 new cases of prostate cancer will be diagnosed in the United States this year, making it one of the most common cancers affecting American men; however, it can be a controversial disease to diagnose and treat now that there is research abounding for both “watchful waiting and aggressive treatments. Dr. Oh supplies balanced information, with articles on: Prostate Cancer: To Screen or Not To Screen?; High Intensity Focused Ultrasound: Ready for Primetime?; The Case for Open vs. Robotic Assisted Laparoscopic Radical Prostatectomy; Primary and Salvage Prostate Cancer Cryotherapy; and The Case for Open vs. Robotic Assisted Laparoscopic Radical Prostatectomy, to name a few. The state-of-the art information presented in this issue make is must-have for all urologists.
UROLOGIC CLINICS OF NORTH AMERICA FORTHCOMING ISSUES February 2023 Biomarkers in Urology Adam Feldman, Editor May 2023 Renal Cancer: Old and New Paradigms Steven Chang and Michael Blute, Editors August 2023 Diversity in Urology Tracy ...
In this issue of Surgical Pathology Clinics, guest editor Dr. Ming Zhou brings his considerable expertise to the topic of Genitourinary Pathology.
This book presents newer advances in diagnosis and treatment of specific cancers, an evidence-based and realistic approach to the selection of cancer treatment, and cutting-edge laboratory developments such as the use of the MALDI technique ...
Increased vitality. More muscle. Improved health. Greater mental agility. These are just a few of the life-enhancing benefits that men with low levels of testosterone can experience when they increase their testosterone level.
Medical and Health Care Books and Serials in Print
Endourology
Other pediatric urologists use a measure of renal pelvic anteroposterior diameter or a combination of classification systems to aid in decision making and risk stratification (Timberlake and Herndon, 2013).
This book represents the most up-to-date, comprehensive textbook in urologic oncology to be published in recent years.
1 Morgan R, Boxall A, Bhatt A, et al. (2011) Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer. Clin Cancer Res 17:1090–8. 2 Whittaker H, Kote-Jarai Z, Ross-Adams H, et al.
Harvard Professor Morgentaler offers a rare view into the secret world of his patients, providing a startling new perspective on men, sex, and relationships.